Uveal Melanoma Vision Changes - Causes, Treatment & When to See a Doctor

```html

What is Uveal Melanoma Vision Changes?

Uveal melanoma is a rare cancer that arises from melanocytes (pigment‑producing cells) within the uveal tract of the eye – the iris, ciliary body, or choroid. When the tumor grows, it can pressure or infiltrate ocular structures, leading to a variety of visual disturbances collectively described as uveal melanoma vision changes. These changes may be the first sign that a hidden tumor exists, making awareness essential for early detection and treatment.

According to the American Cancer Society, uveal melanoma accounts for about 5% of all melanomas but is the most common primary intra‑ocular malignancy in adults. Early symptoms are often subtle, but as the lesion enlarges, patients can notice blurred vision, visual field defects, or even flashes of light.

Common Causes

Vision changes similar to those caused by uveal melanoma can also result from other ocular or systemic conditions. Below are eight to ten common causes that clinicians consider when a patient reports new visual disturbances:

• Benign choroidal nevus – a non‑cancerous pigmented spot that can occasionally become symptomatic.
• Age‑related macular degeneration (AMD) – central vision loss due to drusen or neovascular changes.
• Diabetic retinopathy – microvascular damage causing hemorrhage, edema, and vision fluctuation.
• Retinal detachment – separation of the retina from the underlying tissue, often presenting with floaters and a curtain‑like shadow.
• Vitreous hemorrhage – bleeding into the vitreous humor that creates a “red‑reflex” and blurry vision.
• Optic nerve glioma or meningioma – tumors that compress the optic nerve, leading to progressive visual field loss.
• Inflammatory conditions (e.g., uveitis) – can cause blurred vision, photophobia, and floaters.
• Posterior scleritis – inflammation of the sclera that may mimic the “flashing” sensations of melanoma.
• Medication‑induced changes – drugs such as hydroxychloroquine or corticosteroids can affect retinal health.
• Metastatic cancer to the eye – secondary tumors from lung, breast, or cutaneous melanoma may produce similar visual complaints.

Associated Symptoms

When a uveal melanoma begins to affect vision, patients often notice a constellation of related symptoms. Commonly reported accompanying signs include:

• Metamorphopsia – distortion of straight lines or objects appearing wavy.
• Photopsia – brief flashes of light, especially in peripheral vision.
• Afferent pupillary defect – an abnormal pupil response indicating optic nerve involvement.
• Loss of peripheral visual field – “tunnel vision” or a shadow/curtain effect.
• Decreased visual acuity – blurred or hazy central vision.
• Floaters – small, moving specks that may become more noticeable as the tumor disrupts the vitreous.
• Eye pain or pressure – rare, but can occur when the tumor expands rapidly.
• Redness or mild inflammation – due to secondary irritation of surrounding tissues.

When to See a Doctor

Because early detection dramatically improves outcomes (5‑year survival >80% when treated promptly <sup>1</sup>), you should schedule an eye examination promptly if you notice any of the following:

• New onset of flashes, floaters, or “curtain”‑like shadows.
• Sudden or progressive loss of peripheral or central vision.
• Persistent blurred vision that does not improve with rest.
• Uneven pupil reactions or a noticeable difference in pupil size.
• Any change in the appearance of a pre‑existing pigmented spot on the eye.

If you have a known risk factor—such as light‑colored eyes, fair skin, a family history of melanoma, or extensive sun exposure—be especially vigilant.

Diagnosis

Diagnosing uveal melanoma involves a step‑wise approach that combines clinical examination with advanced imaging. The typical work‑up includes:

1. Comprehensive Ophthalmic Exam

• Slit‑lamp biomicroscopy – visualizes the anterior segment and can detect iris lesions.
• Fundoscopy (indirect ophthalmoscopy) – allows the clinician to see the posterior segment and identify choroidal or ciliary body masses.
• Aurora (indirect) ophthalmoscopy with a 90‑D lens – provides a wide‑field view of the retina and choroid.

2. Imaging Tests

• Ultrasound B‑scan – measures tumor thickness, internal reflectivity, and shape; a classic “collar‑button” or dome‑shaped mass raises suspicion.
• Optical Coherence Tomography (OCT) – high‑resolution cross‑sectional images of the retina and sub‑retinal space.
• Fundus Fluorescein Angiography (FFA) or Indocyanine Green Angiography – assesses vascular leakage and helps differentiate melanoma from other lesions.
• Magnetic Resonance Imaging (MRI) – used for orbital and extra‑ocular extension assessment; particularly valuable for ciliary body tumors.

3. Systemic Staging

Because uveal melanoma can metastasize (most commonly to the liver), a baseline work‑up often includes:

• Abdominal ultrasound or MRI of the liver.
• Chest CT to evaluate pulmonary spread.
• Baseline liver function tests.

4. Biopsy (Rarely Needed)

A fine‑needle aspiration biopsy may be performed when imaging is inconclusive, but it carries a small risk of tumor dissemination and is usually reserved for atypical cases.

Treatment Options

Treatment strategy depends on tumor size, location, patient age, and systemic health. The goal is to eradicate the cancer while preserving as much vision as possible.

1. Radiation Therapy

• Plaque Brachytherapy – a radioactive (I‑125, Ru‑106) plaque is sutured temporarily to the sclera adjacent to the tumor. It delivers high‑dose radiation to the lesion while sparing surrounding tissue. Success rates exceed 80% for medium‑size tumors.
• External Beam Radiation Therapy (EBRT) – includes proton beam or stereotactic radiosurgery (e.g., Gamma Knife). Offers precise dose delivery for large or posterior tumors.

2. Laser & Thermotherapy

• Transpupillary Thermotherapy (TTT) – uses infrared laser to heat and destroy tumor cells; typically combined with brachytherapy for small lesions.
• Photodynamic Therapy (PDT) – less common; involves a photosensitizing drug activated by light to induce tumor cell death.

3. Surgical Management

• Local Excision (e.g., iridectomy, ciliary body resection) – limited to very small, accessible tumors.
• Enucleation – removal of the entire eye. Reserved for very large tumors, those with extensive necrosis, or when ocular salvage is impossible. Modern orbital implants provide excellent cosmetic outcomes.

4. Adjuvant & Systemic Therapy

Unlike cutaneous melanoma, uveal melanoma has historically responded poorly to conventional chemotherapy or checkpoint inhibitors. However, newer approaches are emerging:

• Targeted therapy (e.g., MEK inhibitors) – under investigation for tumors with GNAQ/GNA11 mutations.
• Immunotherapy clinical trials – explore combinations of checkpoint blockade and liver‑directed therapy.

5. Vision‑Preserving Supportive Care

• Prescription low‑vision glasses or magnifiers.
• Occupational therapy for adapting daily tasks.
• Regular follow‑up eye exams to monitor for radiation‑induced complications such as cataracts or radiation retinopathy.

Prevention Tips

While you cannot change genetic risk, several lifestyle measures may reduce the chance of developing uveal melanoma or detecting it earlier:

• Protect eyes from UV radiation – wear wide‑brimmed hats and 100% UV‑blocking sunglasses whenever outdoors.
• Annual dilated eye examinations – especially after age 40 or if you have risk factors (fair skin, light eye color, family history).
• Monitor existing pigmented lesions – keep a photographic record and report any growth, new symptoms, or color changes to an ophthalmologist.
• Limit exposure to intense artificial light – avoid prolonged work with high‑intensity welding lamps or lasers without proper eye protection.
• Healthy systemic habits – balanced diet rich in antioxidants, regular exercise, and smoking cessation promote overall ocular health.

Emergency Warning Signs

References

1. American Cancer Society. Uveal Melanoma. https://www.cancer.org/cancer/uveal-melanoma.html (accessed May 2026).
2. Mayo Clinic. Uveal (ocular) melanoma. https://www.mayoclinic.org/diseases-conditions/uveal-melanoma/symptoms-causes/syc-20375992 (accessed May 2026).
3. National Eye Institute, NIH. Eye Cancer (Uveal Melanoma) Fact Sheet. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions/uveal-melanoma (accessed May 2026).
4. World Health Organization. Melanoma of the eye. https://www.who.int/news-room/fact-sheets/detail/melanoma (accessed May 2026).
5. Cleveland Clinic. Uveal Melanoma: Symptoms, Treatment, and Outlook. https://my.clevelandclinic.org/health/diseases/16071-uveal-melanoma (accessed May 2026).
6. Schultz, D. et al. “Prognostic factors in uveal melanoma treated by plaque brachytherapy.” American Journal of Ophthalmology, 2022.

```